A5089683510- Inflammatory Bowel Disease
- Microscopic Colitis
- Eosinophilic Esophagitis
- Endometriosis Research and Treatment
- Mobile Health and mHealth Applications
- Adolescent and Pediatric Healthcare
- Telemedicine and Telehealth Implementation
- Multiple Sclerosis Research Studies
- SARS-CoV-2 and COVID-19 Research
- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Animal Virus Infections Studies
- Perfectionism, Procrastination, Anxiety Studies
- Primary Care and Health Outcomes
- Celiac Disease Research and Management
- Peripheral Neuropathies and Disorders
- Social Media in Health Education
University of Maryland, Baltimore
2017-2020
INTRODUCTION: Telemedicine has shown promise in inflammatory bowel disease (IBD). The objective of this study was to compare activity and quality life (QoL) a 1-year randomized trial IBD patients receiving telemedicine vs. standard care. METHODS: Patients with worsening symptoms the prior 2 years were eligible for randomization (monitoring via texts EOW or weekly) primary outcomes differences change QoL between groups; healthcare utilization among groups secondary aim. RESULTS: 348...
Inflammatory bowel disease (IBD), comprising Crohn and ulcerative colitis, affects 1 to 3 million people in the United States. Telemedicine has shown promise IBD. The objective of this study, telemedicine for patients with IBD (TELE-IBD), was compare activity quality life (QoL) a 1-year randomized clinical trial receiving versus standard care. Treatment groups experienced improvements QoL, but there were no significant differences between groups. Study adherence text-based intervention less...
Effective treatments are available for patients with inflammatory bowel disease (IBD); however, suboptimal outcomes occur and often linked to patients' limited knowledge. The aim of this analysis was determine if delivery educational messages through a telemedicine system improves IBD knowledge.TELEmedicine Patients (TELE-IBD) randomized controlled trial visits at baseline, 6 months, 12 months; patient knowledge secondary the study. were receive TELE-IBD every other week (EOW), weekly...
Depression is common in patients with inflammatory bowel disease (IBD) and contributes to poor quality of life (QoL). The use information technology for the remote management IBD growing, but little known about its impact on depressive symptoms (DS) QoL. We aimed evaluate telemedicine DS generic QoL patients.We analyzed data from Telemedicine Patients (TELE-IBD) study. During this 12-month clinical trial, were randomized receive text message-based weekly (TELE-IBD W), every other week EOW),...
Depression is common in patients with inflammatory bowel disease (IBD) and known to be associated poor adherence the usual care setting. In last decade, there has been an increase use of information technology (IT) for delivery IBD care, but association between depressive symptoms (DS) self-testing this context not known. We aimed investigate among managed via a text messaging–based telemedicine system. This was prospective study participants 2 intervention arms Telemedicine Patients...
Abstract Background In our clinical practice, women often report excess weight gain with infliximab (IFX) use. There are currently no studies investigating after antitumor necrosis factor therapy in patients inflammatory bowel disease. The objective of this study was to evaluate the association factors, a particular focus on sex and moderate severe Crohn’s disease (CD) or ulcerative colitis (UC) initiating IFX. Methods Data extracted from ACCENT I, II, ACT 1, SONIC; included received IFX for...
Introduction: While effective treatments are available for patients with inflammatory bowel disease (IBD), suboptimal outcomes continue to occur and have been linked many factors including patients' limited knowledge of their disease. Telemedicine has used educate IBD some success. The aim our study was determine if delivery educational messages through a novel telemedicine system can improve knowledge. Methods: Our sub-study the TELEmedicine Patients (TELE-IBD) study. from 3 referral...
IBD affects 1.6 million people in the US and is associated with increased healthcare utilization. Telemedicine an alternative delivery system which could improve outcomes decrease costs. The objective of this study was to compare utilization 1 year before after randomization among participants receiving TELE-IBD standard care. a multicenter, randomized, controlled trial conducted over year. Controls received care whereas completed testing weekly (W) or every other week (EOW). Testing...
Introduction: Telemedicine is increasingly utilized in the care of patients with inflammatory bowel disease (IBD). However, telemedicine requires active patient engagement as symptom monitoring, self-assessment and periodic reporting are needed for optimal health outcomes. Our aim was to identify socio-demographic clinical predictors adherence self-testing IBD enrolled Patients (TELE-IBD) study. Methods: This a prospective cohort study participants 2 intervention arms TELE-IBD Data were...
Inflammatory bowel disease (IBD) is a chronic debilitating condition involving the gastrointestinal (GI) tract that has negative impact on quality of life (QoL). Depressive symptoms (DS) are common in affected patients and contribute to decreased QoL. Telemedicine use information technology remotely deliver health care; it poised gain widespread care IBD patients. However, its effect DS QoL unknown IBD. We investigated telemedicine over time. This was one-year, multicenter, randomized,...
<sec> <title>BACKGROUND</title> Inflammatory bowel diseases (IBD), comprising Crohn’s disease and ulcerative colitis, affects 1 to 3 million people in the United States. Telemedicine has shown promise IBD. The objective of parent study, TELE-IBD, was compare activity quality life (QoL) a one-year randomized clinical trial IBD patients receiving telemedicine versus standard care. Treatment groups experienced improvements QoL but there not significant differences between groups. Study...